Biogen Ma Drug Patent Portfolio
Biogen Ma owns 1 orange book drug protected by 3 US patents Given below is the list of Biogen Ma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10385341 | Compositions for modulating SOD-1 expression | 01 Apr, 2035 | Active |
| US10669546 | Compositions for modulating SOD-1 expression | 01 Apr, 2035 | Active |
| US10968453 | Compositions for modulating SOD-1 expression | 01 Apr, 2035 | Active |
Latest Legal Activities on Biogen Ma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Biogen Ma.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Second letter to regulating agency to determine regulatory review period | 22 May, 2024 | US10385341 |
| Second letter to regulating agency to determine regulatory review period | 22 May, 2024 | US10968453 |
| Second letter to regulating agency to determine regulatory review period | 22 May, 2024 | US10669546 |
| Letter from FDA or Dept of Agriculture re PTE application | 06 Feb, 2024 | US10669546 |
| Letter from FDA or Dept of Agriculture re PTE application | 06 Feb, 2024 | US10385341 |
| Letter from FDA or Dept of Agriculture re PTE application | 06 Feb, 2024 | US10968453 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 01 Feb, 2024 | US10669546 |
|
Email Notification
Critical
| 01 Feb, 2024 | US10669546 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 01 Feb, 2024 | US10968453 |
|
Email Notification
Critical
| 01 Feb, 2024 | US10968453 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 31 Jan, 2024 | US10385341 |
|
Email Notification
Critical
| 31 Jan, 2024 | US10385341 |
| Resp. to req. for info. sent under 37 CFR 1.750 | 21 Dec, 2023 | US10385341 |
| Resp. to req. for info. sent under 37 CFR 1.750 | 21 Dec, 2023 | US10669546 |
| Resp. to req. for info. sent under 37 CFR 1.750 | 21 Dec, 2023 | US10968453 |
Biogen Ma's Family Patents
Biogen Ma Drug List
Given below is the complete list of Biogen Ma's drugs and the patents protecting them.
1. Qalsody
Qalsody is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10385341 | Compositions for modulating SOD-1 expression |
01 Apr, 2035
(10 years from now)
| Active |
| US10669546 | Compositions for modulating SOD-1 expression |
01 Apr, 2035
(10 years from now)
| Active |
| US10968453 | Compositions for modulating SOD-1 expression |
01 Apr, 2035
(10 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qalsody's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List